TR-1: Notification of major holdings | 15-Nov-2024 | 07:00 | RNS |
Encouraging New Product Development Pipeline | 04-Nov-2024 | 07:00 | RNS |
Total Voting Rights | 31-Oct-2024 | 07:00 | RNS |
Further milestone payment triggered post US launch | 07-Oct-2024 | 07:00 | RNS |
Total Voting Rights | 01-Oct-2024 | 07:00 | RNS |
Directors’ / PDMR Dealing | 13-Sep-2024 | 07:00 | RNS |
Trinity Delta research note & consensus forecasts | 11-Sep-2024 | 17:43 | RNS |
Futura Medical - Interim Results 2024 | 10-Sep-2024 | 07:00 | RNS |
Update on US Launch | 02-Sep-2024 | 10:47 | RNS |
Update on US launch | 02-Sep-2024 | 07:00 | RNS |
Notice of Results | 19-Aug-2024 | 07:00 | RNS |
Update on US launch | 01-Aug-2024 | 07:05 | RNS |
Total Voting Rights | 01-Jul-2024 | 14:13 | RNS |
Nominated Adviser and Joint Broker | 01-Jul-2024 | 07:00 | RNS |
Result of AGM | 20-Jun-2024 | 16:12 | RNS |
Currency | UK Pounds |
Share Price | 33.18p |
Change Today | -0.100p |
% Change | -0.30 % |
52 Week High | 45.55p |
52 Week Low | 25.50p |
Volume | 197,710 |
Shares Issued | 303.70m |
Market Cap | £100.75m |
Beta | 0.87 |
RiskGrade | 479 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:23 | 5 @ 33.65p |
16:03 | 8,390 @ 32.83p |
15:48 | 5,500 @ 32.83p |
15:31 | 3,266 @ 32.65p |
15:22 | 802 @ 32.67p |
CEO | James Henry Barder |
Finance Director | Angela Hildreth |
You are here: research